David Wolton has been named vice president manufacturing at CMC Biologics. Mr. Wolton has held positions with Elan, Wyeth and Lonza during his 23-year biotech career.

“We are delighted to add David’s tremendous experience to CMC Biologics.He has a proven track record in managing successful manufacturing teams and will bring new opportunities for production efficiencies,” said Peter Vilby, CMC’s chief operating officer.

“CMC Biologics continues to attract the highest caliber people in our industry, and David Wolton’s appointment will ensure continued delivery of products to our customers,in the highly demanding regulatory environment of biologicals,” said Mads Laustsen, the company’s chief executive officer.